March 07, 2019

Deal Snapshot: Biogen & Nightstar Therapeutics

Median deal values by quarter


Biogen Key BD Contacts

  • Head BD&L, Neuromuscular, Movement Disorders, Acute Neurology, Gene Therapy & Biosimilars | Jill Branca
  • Head BD&L, MS, AD, Optha, Pain, Neurocognition, and Platforms | Kleem Chaudhary
  • Director & Head, Corporate Strategy | Susan Langer

Biogen Deal Activity by Therapeutic Area (Last 3 Years)

Recent deal activity by disease area

Recent In-Licensing Deals and Acquisitions:

Biogen Pipeline Composition

Pipeline composition, disease areas


Business profiles tailored to your asset.